Abiopharma

🔍 McManus Matt (Executive)

Company: Fold Holdings, Inc. (FLD)

Report Date: 2026-04-22

Detailed Transactions and Holdings:

• Sold 9,924 shares of Common Stock at $1.504 per share (Direct)
  Date: 2026-04-22 | Code: S | equity_swap_involved: false | shares_owned_after: 384,988.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The sale reported on this Form 4 represents shares sold by Mr. McManus to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by Mr. McManus.
• REMARKS: Exhibit 24 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24 to the Form 4 filed by Mr. McManus on April 14 2026).